Yayın:
The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome

dc.contributor.authorTabak, Omur
dc.contributor.authorSimsek, Gonul
dc.contributor.authorErdenen, Fusun
dc.contributor.authorSozer, Volkan
dc.contributor.authorHasoglu, Tuna
dc.contributor.authorGelisgen, Remise
dc.contributor.authorAltunoglu, Esma
dc.contributor.authorMuderrisoglu, Cuneyt
dc.contributor.authorSenyigit, Abdulhalim
dc.contributor.authorUzun, Hafize
dc.date.accessioned2026-06-27T14:12:45Z
dc.date.issued2017
dc.description.abstractObjective: We wanted to investigate whether there is a relationship between circulating irisin, retinol binding protein-4 (RBP-4), adiponectin and proinflammatory mediators implicated in the development of insulin resistance (IR) in metabolic syndrome (MetS). Subjects and methods: In 180 individuals, including controls and patients with MetS, we measured fasting plasma insulin, high sensitivity C-reactive protein (hsCRP), pentraxin-3 (PTX-3), interleukin-33 (IL-33), irisin, RBP-4, and adiponectin using ELISA kits. Results: While fasting plasma hsCRP, PTX-3, IL-33, irisin, RBP-4 concentrations were higher, adiponectin levels were lower in patients with MetS than in controls. A correlation analysis revealed that plasma irisin levels were positively associated with MetS components such as waist circumference and waist-hip ratio, low density lipoprotein (LDL) and markers of systemic inflammation such as PTX-3, hsCRP, uric acid, and RBP-4. Adiponectin levels were negatively associated with waist circumference, waist-hip ratio, PTX-3 and LDL. Conclusions: Although the precise mechanisms are still unclear, irisin, RBP-4, adiponectin and PTX-3 are hallmarks of the MetS, which is related to low-grade inflammation. It is conceivable that irisin and adiponectin might contribute to the development of MetS and may also represent novel MetS components. Future clinical studies are needed to confirm and extend these data.en
dc.description.urihttps://doi.org/10.1590/2359-3997000000289
dc.identifier.doi10.1590/2359-3997000000289
dc.identifier.eissn2359-4292
dc.identifier.endpage523
dc.identifier.issn2359-3997
dc.identifier.issue6
dc.identifier.pubmed28977161
dc.identifier.startpage515
dc.identifier.urihttps://hdl.handle.net/20.500.14981/58010
dc.identifier.volume61
dc.identifier.wos000424375800003
dc.language.isoeng
dc.publisherSBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
dc.relation.ispartofARCHIVES OF ENDOCRINOLOGY METABOLISM
dc.rightsopenAccess
dc.subjectMetabolic syndrome
dc.subjecthigh sensitivity C-reactive protein
dc.subjectpentraxin-3
dc.subjectinterleukin-33
dc.subjectirisin
dc.subjectretinol binding protein-4
dc.subjectadiponectin
dc.subjectTYPE-2 DIABETES-MELLITUS
dc.subjectPLASMA PENTRAXIN 3
dc.subjectINSULIN-RESISTANCE
dc.subjectASSOCIATION
dc.subjectADIPOKINES
dc.subjectPTX3
dc.subjectRBP4
dc.subjectEndocrinology & Metabolism
dc.titleThe relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar